by Industry News
New York, NY – November 8, 2018 – Optima Molliter has won the "CES 2019 Innovation Awards Honoree in Wearable Technologies" for the "SBi Motus Smart" project. The announcement paves the way to the Company's quest for the "CES Innovation Awards," that will be presented during the January event by the Consumer Technology Association (CTA).
This important achievement makes Optima Molliter the first Company in the field of wound care and orthopedic rehabilitation to establish itself in the global technological market, bringing the theme of the treatment and prevention of plantar diabetic ulcer to the CES.
"We believe that movement is freedom. And we work to allow people to be constantly on the move." This is how CEO and co-owner Susanna Salvatelli summarizes the philosophy behind the corporate strategies of choice. "Optima Molliter considers the uniqueness of each individual to study customizable solutions that can support patients on the basis of their conditions."
The SBi Motus Smart project was born of the Company's intent to engineer and industrialize the solution of one of the major problems related to the risk of ulcers and amputations in patients with diabetes. Thanks to this project, Optima Molliter allows the world market to count on customizable devices that, adjusted to each patient's discrete physical attributes, guarantee complete movement self-sufficiency and total discretion.
The mission was to create an effective, performing, resistant and easy-to-use leg-foot walker. The aim is to significantly reduce healing time, enhancing quality of life and allowing patients as much self-sufficiency and individuality as possible.
The SBi structure implemented with sensors manufactured by Sensoria (a US company specialized in the artificial intelligence sector linked to the sportswear world) gives life to the first walker in the world which monitors patients' adherence to therapy in real time: by measuring patients' performance and parameters 24/7, it ensures communication between medical institutions and wearers, reporting anomalies, incorrect behavior, risk situations or providing any relevant information to wearing patients.
"People are our best technology," says Franco Salvatelli, (Head of R&D Department and co-owner), reaffirming the importance the Company places on research & development, which every year is allocated 20% of the comprehensive corporate turnover. The professionalism honed in previous design experiences has given Optima Molliter valuable know-how in the matter of wearable sensorial care/rehab devices, thus leading to the birth of the SBi Motus Smart project.
Optima Molliter will participate in the 2019 edition of CES, in Las Vegas, from January 8-11, 2019.
About Optima Molliter
Headquartered in Italy, Optima Molliter designs, manufactures and distributes in 22 countries around the world diabetic walkers for mechanical offloading of foot injuries (diabetic, ischemic, traumatic or post-surgical) and footwear for prevention (MAC1), rehabilitation (MAC2-3) and daily activity shoes (YDA).
The views and opinions expressed in this blog are solely those of the author, and do not represent the views of WoundSource, Kestrel Health Information, Inc., its affiliates, or subsidiary companies.